|01 December 2017|
|Listed Products Daily Turnover in November Averaged S$97 Million|
Listed Products Daily Turnover In November Averaged S$97 Million
SGX listed Structured Warrants, DLCs and ETFs generated a combined daily average turnover of S$97 million with Structured Warrants contributing S$74 million (+163% Y-o-Y) of the total.
Structured warrants generated a total turnover of S$1,624 million in November with majority of the turnover in the warrants with Hang Seng Index underlying. The five most active index warrants on the Hang Seng Index in November and recent warrant listings are tabled below.
Top 5 Most Active Index Warrants in November
Source: SGX (data as of 30 November 2017)
Newly Listed Structured Warrants
Source: SGX (data as of 30 November 2017)
Click here to see more recent listings
DLCs Generated a Total Turnover of S$282 million in November
The DLCs have generated a total turnover of S$282 million in November and a total of S$1.55 Billion since its launch.
The DLCs are designed to be traded on a short term basis where investors can use them to capture intraday trends in the market or trends over a few days. See an extract from the daily newsletter by SocGen below showcasing the product returns on one of the more active days this month, 21 November. The largest intraday DLC move was in the HSCEI that day with more than 14.5% gain or loss.
Investors should note that the 5 times leveraged performance in the DLC is calculated on a close-to-close basis and performance of the DLC will vary from 5 times when held for more than one day due to the compounding effect. To read more about the features of the DLC, download the brochure here.
There are currently 10 DLCs available for trading on SGX and the details are highlighted in the table below.
*[DLC] [Issuer][Leverage factor][Long or Short][Underlying Index] [Expiry Date in YYMMDD]
**DLCs track the total return index of the respective underlying indices
ETF daily average traded value at S$10.4million in November
ETFs traded S$10.4 million on average a day in the month of November, up 35% from the month before.
The top 5 traded ETFs include iShares MSCI India, SPDR® STI ETF, DBXT MSCI AC Asia ex Japan ETF, SPDR® Gold Shares and the newly-listed Lion-Phillip S-REIT ETF.
The iShares MSCI India has produced an YTD return of 30.45%. Shares of Britannia (BSE), Vakrangee (BSE) and Petronet LNG (BSE) were trading higher after these stocks were included in the MSCI India index with effect from December 1, 2017.
The SPDR® STI ETF has produced an YTD return of 22.51%. SGX lists 2 ETFs that tracks the Straits Times Index - SPDR® STI ETF and NikkoAM STI ETF. The Lion-Phillip S-REIT ETF started trading on SGX on 30th October 2017. As of 30th November 2017, the ETF produced a return of 2.7%, as the ETF closed at $1.027, up from the initial launch price of S$1.00.
* Dual currency traded ETF. Turnover and no. of trades is the total of the USD and SGD counters.
Specified Investment Products
Structured warrants and Daily Leverage Certificates are examples of Specified Investment Products (SIPs). The MAS has introduced measures for intermediaries to safeguard the interests of individual investors investing in SIPs, which are products with features that might be more complex in nature. Investors now have the opportunity to assess their qualifications to trade SIP or enhance their product knowledge through the SGX online portal available here. Speak to your broker to find out how you can qualify to trade SIPs.
Education and Resources
SGX’s investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.
Nikkei owns the copyright and any other intellectual property rights in the Nikkei Stock Average itself, and the method for calculating the Nikkei Stock Average and the like. All ownership of trademarks and any other intellectual property rights with respect to marks representing "Nikkei Inc.," "Nikkei," and "Nikkei Stock Average" belongs to Nikkei. Nikkei is not obliged to continuously publish the Nikkei Stock Average, nor is it liable for any error or delay in, or discontinuation of the publication thereof. Nikkei owns the right to change the content of the Nikkei Stock Average, such as the calculation method thereof, and the right to suspend the publication thereof. Nikkei does not give any warranty, nor is it responsible for any and all financial instruments and the like, which are based on, or otherwise refer to, the Nikkei Stock Average.
All rights in the FTSE China A50 Index (the “Index”) vest in FTSE International Limited (“FTSE”). “FTSE®” is a trademark of the London Stock Exchange Group companies and is used by FTSE under license.
The SGX FTSE China A50 Index Futures (the "Product") has been developed solely by Singapore Exchange Derivatives Trading Limited. The Index is calculated by FTSE or its agent. FTSE and its licensors are not connected to and do not sponsor, advise, recommend, endorse or promote the Product and do not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Index or (b) investment in or operation of the Product. FTSE makes no claim, prediction, warranty or representation either as to the results to be obtained from the Product or the suitability of the Index for the purpose to which it is being put by Singapore Exchange Derivatives Trading Limited.
Futures or options contract on any MSCI Index are not sponsored, guaranteed, endorsed, sold or promoted by MSCI, any affiliate of MSCI or any other party involved in, or related to, making or compiling any indexes (but expressly including the exchange) MSCI bears no liability of any kind with respect to such contracts